Company / Capital Expenditures
CHAMPIONS ONCOLOGY, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$836.0K
FY2025
5-year range
$389.0K / $3.3M
FY2021-FY2025
Trend
+114.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $836,000.
Based on SEC 10-K filings.
$836,000 in FY2025 with a 5-year CAGR of -23.9%.
Declined from $2M to $836,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -36.6%
- 5-Year CAGR
- -23.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -23.9%, indicating a declining trend.
- In FY2025, capital expenditures increased 114.9% year-over-year.
- Peak capital expenditures was recorded in FY2022.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $836.0K | +114.9% |
| FY2024 | $389.0K | -83.7% |
| FY2023 | $2.4M | -27.3% |
| FY2022 | $3.3M | +47.8% |
| FY2021 | $2.2M | -32.3% |
| FY2020 | $3.3M | +47.8% |
| FY2019 | $2.2M | +189.8% |
| FY2018 | $766.0K | +137.9% |
| FY2017 | $322.0K | +170.6% |
| FY2016 | $119.0K | -49.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026